Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Given CJC-1295s status as a research chemical, any claims about this peptide's purported benefits have not been confirmed by human clinical trials and any statements online have not been evaluated by the FDA
Metabolic and homeostatic changes in seizures and acquired epilepsy-mitochondria, calcium dynamics and reactive oxygen species
From the small-batch synthesis of our compounds to the exact amino-acid sequencing, we believe that reproducible, high-quality research starts with impeccable materials
All information presented here is neutral, factual, and intended to support scientific discussion rather than clinical, therapeutic, or diagnostic application
The peptide is created by adding 13 amino acids to the N-terminal end of IGF-1 and by converting the glutamic acid at position 3 of IGF-1 to an arginine residue
